Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

Regulatory Toxicology and Pharmacology

Volumn 63, Issue 2, 2012, Pages 196-208

  Clarke, Kieran ^a   Tchabanenko, Kirill ^a,d   Pawlosky, Robert ^b   Carter, Emma ^a   Knight, Nicholas S ^a   Murray, Andrew J ^a,e   Cochlin, Lowri E ^a   King, M Todd ^b   Wong, Andrea W ^c   Roberts, Ashley ^c   Robertson, Jeremy ^a   Veech, Richard L ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c Intertek Cantox   (Canada)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

(R) 3 Hydroxybutyl (R) 3 hydroxybutyrate; Developmental toxicity; Ketones; Safety; Toxicity

Indexed keywords

3 HYDROXYBUTYL 3 HYDROXYBUTYRATE; KETONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BLOOD CLOTTING TIME; BODY WEIGHT; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; FEMALE; FETUS; FETUS WEIGHT; GESTATIONAL AGE; LITTER SIZE; LONG TERM EXPOSURE; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; RAT; TOXICITY TESTING; URINALYSIS; WEIGHT GAIN;

ANIMALIA; RATTUS;

EID: 84861137360     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.04.001     Document Type: Article

References (42)

1. Carter, E. et al., unpublished. Human Plasma Esterase Activity Study Report.
2. Clarke, K. et al., submitted for publication. Kinetics, safety and tolerability of d-β-hydroxybutyrate-(R)-1,3-butanediol monoester in healthy adult subjects. Regul. Toxicol. Pharmacol.: RTP.
3. Desrochers S., et al. Metabolism of R- and S-1,3-butanediol in perfused livers from meal-fed and starved rats. Biochem. J. 1992, 285:647-653.
4. Desrochers S., et al. Metabolism of (R,S)-1,3-butanediol acetoacetate esters, potential parenteral and enteral nutrients in conscious pigs. Am. J. Physiol. 1995, 268:E660-E667.
5. Dunn O.J. Multiple comparisons using rank sums. Technometrics 1964, 6:241-252.
6. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 1955, 50:1096-1121.
7. Friedel R., Mattenheimer H. Release of metabolic enzymes from platelets during blood clotting of man, dog, rabbit and rat. Clin. Chim. Acta 1970, 30:37-46.
8. Friedel R., et al. Effects of blood sampling on enzyme activities in the serum of laboratory animals. Z. Klin. Chem. Klin. Biochem. 1974, 12:229.
9. Hempenius R.A., Lina B.A.R., Haggitt R.C. Evaluation of a subchronic (13-week) oral toxicity study, preceded by an in utero exposure phase, with arachidonic acid oil derived from Mortierella alpina in rats. Food Chem. Toxicol. 2000, 38:127-139.
10. Hess F.G., et al. Reproduction and teratology study of 1,3-butanediol in rats. J. Appl. Toxicol. 1981, 1:202-209.
11. Hunter E.S., Sadler T.W., Wynn R.E. A potential mechanism of d,l-β-hydroxybutyrate-induced malformations in mouse embryos. Am. J. Physiol. 1987, 253:E72-E80.
12. Johnstone A.M., et al. Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Am. J. Clin. Nutr. 2008, 87:44-55.
13. Kashiwaya Y., et al. d-Beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc. Natl. Acad. Sci. USA 2000, 97:5440-5444.
14. Kashiwaya Y., et al. A ketone ester diet increases brain malonyl-CoA and uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar rat. J. Biol. Chem. 2010, 285:25950-25956.
15. Kies C., et al. Utilization of 1,3-butanediol and nonspecific nitrogen in human adults. J. Nutr. 1973, 103:1155-1163.
16. Knight, N.S. et al., unpublished. A (R)-1,3-Butanediol-d-β-hydroxybutyrate ester diet improves physical and mental performance in rats.
17. McClernon F.J., et al. The effects of a low-carbohydrate ketogenic diet and a low-fat diet on mood, hunger, and other self-reported symptoms. Obesity (Silver Spring) 2007, 15:182-187.
18. McPherson, P.A., McEneny, J., 2011. The biochemistry of ketogenesis and its role in weight management, neurological disease and oxidative stress. J. Physiol. Biochem. (Advance, Publication - Oct. 8, 2011).
19. Moley K.H., Vaughn W.K., Diamond M.P. Manifestations of diabetes mellitus on mouse preimplantation development: effect of elevated concentration of metabolic intermediates. Hum. Reprod. 1994, 9:113-121.
20. National Research Council Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
21. OECD, 1998. OECD Principles of Good Laboratory Practice (as Revised in 1997), OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring, No. 1 - ENV/MC/CHEM(98)17). Organisation for Economic Co-operation and Development (OECD), Environment Directorate, Chemicals Group and Management Committee, OECD Environmental Health and Safety Publications. Available at: http://www.oecd.org/officialdocuments/displaydocumentpdf/?cote=env/mc/chem(98)17&doclanguage=en.
22. Plecko B., et al. Oral β-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of β-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. Pediatr. Res. 2002, 52:301-306.
23. Puchowicz M.A., et al. Dog model of therapeutic ketosis induced by oral administration of R,S-1,3-butanediol diacetoacetate. J. Nutr. Biochem. 2000, 11:281-287.
24. Reger M.A., et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol. Aging 2004, 2:311-314.
25. Ruben, Z. et al., 2000. Non-proliferative lesions of the heart and vasculature in rats. In: Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, DC. Available at: http://www.toxpath.org/ssdnc/CardiovascularNonprolifRat.pdf.
26. Sato K., et al. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 1995, 9:651-658.
27. Scala R.A., Paynter O.E. Chronic oral toxicity of 1,3-butanediol. Toxicol. Appl. Pharmacol. 1967, 10:160-164.
28. Sheehan E.A., et al. Effects of beta-hydroxybutyrate on rat embryos grown in culture. Experientia 1985, 41:273-275.
29. Siegel S. The Fisher's exact probability test. Nonparametric Statistics for the Behavioral Sciences 1956, 96-105. McGraw-Hill Co., New York, NY.
30. Snedecor G.W., Cochran W.G. Variance test for homogeneity of the binomial distribution. Statistical Methods 1967, 240-241. Iowa State University Press, Ames. sixth ed.
31. Snedecor G.W., Cochran W.G. Analysis of variance. Statistical Methods 1967, 258-298. Iowa State University Press, Ames. sixth ed.
32. Sokal R.R., Rohlf F.J. Bartlett' s test of homogeneity of variances. Biometry: The Principles and Practice of Statistics in Biological Research 1969, 370-371. Freeman & Co., San Francisco.
33. Sokal R.R., Rohlf F.J. Kruskal-Wallis test. Biometry: The Principles and Practice of Statistics in Biological Research 1969, 388-391. Freeman & Co., San Francisco.
34. Stanfield C.L., Germann W.J. Cell metabolism. Principles of Human Physiology 2008, 58-93. Pearson Benjamin Cummings, San Francisco. third ed.
35. Staples R.E. Detection of visceral alterations in mammalian fetuses. Teratology 1974, 9:A37-A38.
36. Staples R.E., Schnell V.L. Refinements in rapid clearing technic in the KOH-alizarin red S method for fetal bone. Stain Technol. 1964, 39:61-63.
37. Tate R.L., Mehlman M.A., Tobin R.B. Metabolic fate of 1,3-butanediol in the rat: conversion to -hydroxybutyrate. J. Nutr. 1971, 101:1719-1726.
38. US FDA, 2000. IV.C.9.b Guidelines for developmental toxicity studies. In: Toxicological principles for the safety assessment of food ingredients: FDA Redbook 2000 [Updated to July, 2007]. US Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Silver Spring, MD. Available at: http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredientsandPackaging/Redbook/ucm078399.htm.
39. US FDA, 2003. IV.C.3.a Short-term toxicity studies with rodents. In: Toxicological principles for the safety assessment of food ingredients: FDA Redbook 2000 (Updated to July, 2007). US Food and Drug Administration (US FDA), Center for Food Safety and Applied Nutrition (CFSAN), Silver Spring, MD. Available at: http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodIngredientsandPackaging/Redbook/ucm078339.htm.
40. US FDA, 2011. Part 58 - Good laboratory practice for nonclinical laboratory studies. In: US Code of Federal Regulations (CFR). Title 21 - Food and Drugs (Food and Drug Administration). US Government Printing Office (GPO), Washington, DC. Available at: http://www.gpo.gov/fdsys/browse/collectionCfr.action?collectionCode=CFR.
41. Wilson J.G. Methods for administering agents and detecting malformations in experimental animals. Teratology: Principles and Techniques 1965, 262-277. University of Chicago Press, Chicago. J.G. Wilson, J. Warkany (Eds.).
42. Yerrourn M., Braconnier F., Chariot P. Influence of handling procedures on rat plasma creatine kinase activity. Muscle Nerve 1999, 22:1119-1121.